INVESTIGATION OF THE MEDICATION USE IN PATIENTS WITH ACUTE CORONARY SYNDROME AT THONG NHAT HOSPITAL

Nguyễn Khánh Gia Bảo1, Nguyễn Văn Tân2, Trần Quỳnh Như2, Bùi Thị Hương Quỳnh1,2,
1 University of Medicine and Pharmacy at Ho Chi Minh City
2 Thong Nhat Hospital, Ho Chi Minh City

Main Article Content

Abstract

Background: Acute coronary syndrome is responsible for about 40% of deaths caused by cardiovascular diseases each year. Nowadays, there are many guidelines for the diagnosis and treatment of acute coronary syndrome. Objectives: To investigate the medication use of ACEIs or ARBs, beta-blockers, and statins in the first 24 hours of admission and in hospital discharge prescriptions in patients with acute coronary syndrome at Thong Nhat Hospital, Ho Chi Minh City. Method: A cross-sectional study was conducted on medical records of patients with hospital discharge diagnosis of non-ST elevation myocardial infarction, ST-elevation myocardial infarction or unstable angina at Thong Nhat Hospital from April 2020 to August 2020. Collected data for analysis included characteristics of patients with acute coronary syndrome, characteristics and rationality of ACEIs or ARBs, beta-blockers, and statins during the first 24 hours of admission and in hospital discharge prescriptions. Results: The median age of 174 patients was 64.5 (55–75), 71.3% was male. The majority of patients had comorbidities, of which hypertension was the most common one (94.8%). Within the first 24 hours of hospitalization, the proportions of patients who had an appropriate indication for ACEIs/ ARBs, beta-blockers, and statins were 62.6, 28.7 and 81.6%, respectively. The guideline adherence rates in hospital discharge prescriptions for ACEIs/ ARBs, beta-blockers, and statins were 84.5, 29.7 and 87.1%, respectively. Conclusion: The guideline adherence rate in patients with acute coronary syndromes after discharge was higher than in the first 24 hours of admission. Further adherence to treatment guidelines is required to optimize the treatment outcome in patients with acute coronary syndrome.

Article Details

References

1. World Health Organization (2017), "Disease burden and mortality estimates: cause-specific mortality, 2000–2016", Available: https:// www.who.int/healthinfo/global_burden_disease/estimates/en/index1.html [Access: Dec 1, 2019].
2. Amsterdam E. A., Wenger N. K., Brindis R. G. et al. (2014), "2014 AHA/ACC guideline for the management of patients with non–ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines", J Am Coll Cardiol, 64(24), e139-e228.
3. Bộ Y tế Việt Nam (2019), Hướng dẫn chẩn đoán và xử trí hội chứng mạch vành cấp, Nhà xuất bản Y học, Hà Nội.
4. Ibanez B., James S., Agewall S. et al. (2018), "2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC)", Eur Heart J, 39(2), 119-177.
5. O'Gara P. T., Kushner F. G., Ascheim D. D. et al. (2013), "2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines", J Am Coll Cardiol, 61(4), e78-e140.
6. Roffi M., Patrono C., Collet J.-P. et al. (2016), "2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC)", Eur Heart J, 37(3), 267-315.
7. Nguyễn Lân Việt, Phạm Gia Khải , Đặng Vạn Phước và cs. (2016), "Khuyến cáo về chẩn đoán và xử trí bệnh nhân bị hội chứng mạch vành cấp không ST chênh lên", Hội Tim mạch học Việt Nam.
8. Bộ Y tế Việt Nam (2015), Dược thư quốc gia Việt Nam, Nhà xuất bản Y học, Hà Nội.
9. Phạm Hoà Bình, Hồ Thượng Dũng, Châu Văn Vinh (2011), "Nhận xét về điều trị nhồi máu cơ tim cấp tại Bệnh viện Thống Nhất TP. Hồ Chí Minh từ 01/2009-06/2010", Y học TP.Hồ Chí Minh, 15(2), 170-176.
10. Hồ Đăng Duẫn, Châu Ngọc Hoa (2017), "Tần số tim và sự sử dụng thuốc chẹn bêta ở bệnh nhân hội chứng vành cấp", Y học TP. Hồ Chí Minh, 21(1), 179-184.
11. Nguyễn Đức Công, Hồ Thượng Dũng , Châu Văn Vinh và cs. (2014), "Đặc điểm lâm sàng, cận lâm sàng và điều trị bệnh nhân có hội chứng vành cấp tại BV. Thống Nhất TP. Hồ Chí Minh từ 01.2013 đến 06.2013", Y học TP. Hồ Chí Minh, 18(3), 26-29.